創薬インフォマティクス市場規模、シェア、成長分析、機能別、用途別、ソリューション別、エンドユーザー別、地域別 - 産業予測、2025-2032年

創薬インフォマティクスの世界市場規模は2023年に32億9,000万米ドルと評価され、2024年の36億6,000万米ドルから2032年には86億2,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは11.3％で成長する見通しです。

世界の創薬インフォマティクス市場は、バイオテクノロジー企業や製薬企業による研究投資の強化に加え、希少疾病治療や希少疾病治療薬の開発に対する需要の高まりによって大きな成長を遂げています。このような研究費の急増は、創薬におけるデータ管理の重要な役割を浮き彫りにしており、医薬品や化合物に関する広範なデータベースは医薬品研究に不可欠です。現代のインフォマティクスは、ハイパフォーマンス・コンピューティングとオンラインサービスの向上に支えられ、効果的なデータ処理、管理、分析のために高度なソフトウェアを採用しています。さらに、医薬品開発への注目の高まり、新規治療薬へのニーズの高まり、インシリコ解析の普及が、市場拡大をさらに後押ししています。しかし、インフォマティクス・ツールに関連する高コストが成長の妨げになる可能性がある一方、発展途上国の新興バイオテクノロジー分野には有利な機会があります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析
• 技術分析
• 特許分析

創薬インフォマティクス市場規模：機能別

• 市場概要
• シーケンスとターゲットデータ分析
• ドッキング
• 分子モデリング
• ライブラリとデータベースの準備
• その他の機能

創薬インフォマティクス市場規模：用途別

• 市場概要
• 創薬
• 医薬品開発
  • 臨床前試験
  • 臨床試験

創薬インフォマティクス市場規模：ソリューション別

• 市場概要
• ソフトウェア
• サービス

創薬インフォマティクス市場規模：エンドユーザー別

• 市場概要
• 製薬会社
• バイオテクノロジー企業
• 調査業務受託機関（CRO）
• その他のエンドユーザー

創薬インフォマティクス市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• IBM（United States）
• Infosys Limited（India）
• Thermo Fisher Scientific（United States）
• PerkinElmer Inc.（United States）
• Schrodinger, Inc.（United States）
• Charles River Laboratories International, Inc.（United States）
• Certara, Inc.（United States）
• Accenture plc（Ireland）
• Agilent Technologies, Inc.（United States）
• Illumina, Inc.（United States）
• Dassault Systemes SE（France）
• Collaborative Drug Discovery, Inc.（United States）
• Eurofins DiscoverX Products（United States）
• Jubilant Biosys Limited（India）
• Selvita S.A.（Poland）
• Novo Informatics Pvt. Ltd.（India）
• ChemAxon Ltd.（Hungary）
• Albany Molecular Research Inc.（United States）
• Boehringer Ingelheim GmbH（Germany）
• Oracle Corporation（United States）

結論と提言

Global Drug Discovery Informatics Market size was valued at USD 3.29 billion in 2023 and is poised to grow from USD 3.66 billion in 2024 to USD 8.62 billion by 2032, growing at a CAGR of 11.3% during the forecast period (2025-2032).

The global drug discovery informatics market is witnessing significant growth driven by rising demand for rare illness treatments and orphan drug development, alongside enhanced research investment by biotechnology and pharmaceutical companies. This surge in research expenditure highlights the vital role of data management in drug discovery, where extensive databases of drugs and compounds are essential for pharmaceutical research. Modern informatics employs advanced software for effective data processing, management, and analysis, supported by improvements in high-performance computing and online services. Additionally, the growing focus on drug development, increasing need for new therapeutics, and widespread adoption of in silico modeling technology further propel market expansion. However, the high costs associated with informatics tools may hinder growth, while emerging biotech sectors in developing nations present lucrative opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Informatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Informatics Market Segments Analysis

Global Drug Discovery Informatics Market is segmented by Function, Application, Solution, End User and region. Based on Function, the market is segmented into Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation and Other functions. Based on Application, the market is segmented into Drug Discovery and Drug Development. Based on Solution, the market is segmented into Software and Services. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs) and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Discovery Informatics Market

The global drug discovery informatics market is significantly propelled by the swift developments in technology, especially in artificial intelligence (AI) and machine learning (ML). These innovations enhance data analysis capabilities, enabling researchers to process vast amounts of information swiftly and accurately. This increased efficiency not only streamlines the identification of molecular candidates for drug development but also expedites the overall drug discovery process. By harnessing powerful algorithms and predictive analytics, AI and ML are revolutionizing how pharmaceutical companies approach drug development, thereby driving the growth of the drug discovery informatics market on a global scale.

Restraints in the Global Drug Discovery Informatics Market

The Global Drug Discovery Informatics market faces significant obstacles due to concerns surrounding data protection and the necessity to adhere to legal regulations. Compliance with privacy laws, such as the General Data Protection Regulation (GDPR), complicates the management and sharing of critical information. As a result, these regulatory challenges hinder research efforts and create barriers that limit the adoption of advanced informatics technologies by companies. Consequently, this situation stifles innovation and growth within the market, making it increasingly difficult for organizations to leverage new insights and capabilities essential for advancing drug discovery processes on a global scale.

Market Trends of the Global Drug Discovery Informatics Market

The Global Drug Discovery Informatics market is witnessing a significant trend towards the increasing adoption of artificial intelligence (AI) and machine learning (ML) technologies. This shift is revolutionizing the industry by enhancing data analysis capabilities, expediting the identification of potential drug candidates, and leveraging predictive modeling to streamline the drug discovery process. As a result, pharmaceutical companies and research institutions are experiencing heightened creativity and operational efficiency, driving the demand for advanced informatics solutions. This trend indicates a transformative approach to drug discovery, promising more innovative therapies and faster time-to-market, thus positioning AI and ML as pivotal elements in the future of pharmacological research.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Patent Analysis

Global Drug Discovery Informatics Market Size by Function & CAGR (2025-2032)

• Market Overview
• Sequencing and Target Data Analysis
• Docking
• Molecular Modelling
• Library & Database Preparation
• Other functions

Global Drug Discovery Informatics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
• Drug Development
  • Preclinical Testing
  • Clinical Trials

Global Drug Discovery Informatics Market Size by Solution & CAGR (2025-2032)

• Market Overview
• Software
• Services

Global Drug Discovery Informatics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organization (CROs)
• Other End Users

Global Drug Discovery Informatics Market Size & CAGR (2025-2032)

• North America (Function, Application, Solution, End User)
  • US
  • Canada
• Europe (Function, Application, Solution, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Function, Application, Solution, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Function, Application, Solution, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Function, Application, Solution, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IBM (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infosys Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schrodinger, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certara, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accenture plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collaborative Drug Discovery, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins DiscoverX Products (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Biosys Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Selvita S.A. (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Informatics Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ChemAxon Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Albany Molecular Research Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations